Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow Quality Index
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow Quality Index of 1.35x as of March 2025. Operating cash flow of Rs4.65 Billion exceeds net income of Rs3.45 Billion, indicating high earnings quality where cash backs reported profits. Explore how efficiently does Akums Drugs and Pharmaceutical generate cash to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Akums Drugs and Pharmaceutical Cash Flow Quality Index (2023–2025)
Historical Cash Flow Quality Index for Akums Drugs and Pharmaceutical across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Akums Drugs and Pharmaceutical investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Akums Drugs and Pharmaceutical (2023–2025)
Year-by-year earnings quality comparison for Akums Drugs and Pharmaceutical. For live market cap and the full company financial profile, see market cap of Akums Drugs and Pharmaceutical.
| Year | Quality Index | Operating CF (INR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | Rs4.65 Billion | Rs3.45 Billion | ▲ +14.7% |
| 2023 | 1.18x | Rs1.77 Billion | Rs1.50 Billion | — |